Henry E. Pelish Net Worth
Track Major Insider Updates On X/TwitterLast Updated: 1 day, 13 hours ago
Henry E. Pelish has an estimated net worth of at least $19.9 million*, as of April 29, 2026. They own 68,697 shares of NUVL stock. They have sold 141,280 shares of NUVL stock since 2021, for an estimated $13.0 million.
Henry E. Pelish $NUVL SEC Form 4 Insider Trading
Henry E. Pelish has filed a total of 43 insider trades in $NUVL since 2021. Their most recent trade was a sale of 2,193 shares, made on Apr 09, 2026. Their largest trade was a sale of 24,189 shares, made on Mar 12, 2026. We estimate that they now own 68,697 shares of $NUVL, worth an estimated $6.9 million.
Insider Trading at $NUVL
There have been a total of 531 insider trades reported at $NUVL since 2021, with 1.5 million shares purchased and 7.2 million shares sold. The most active insider traders in $NUVL stock have been Darlene Noci, Deborah Ann Miller, and Alexandra Balcom. The most recent trade was a sale of 900 shares reported by Henry E. Pelish (Chief Scientific Officer), made on Apr 09, 2026.
History of Insider Stock Trades by Henry E. Pelish
| Company Ticker | Purchase / Sale | Shares | Date | Disclosed (EST) |
|---|---|---|---|---|
NUVL
|
Sale | 2,193 | Apr 09, 2026 | April 13, 2026, 4:30 p.m. |
NUVL
|
Sale | 900 | Apr 09, 2026 | April 13, 2026, 4:30 p.m. |
NUVL
|
Sale | 2,597 | Mar 13, 2026 | March 16, 2026, 4:31 p.m. |
NUVL
|
Sale | 804 | Mar 13, 2026 | March 16, 2026, 4:31 p.m. |
NUVL
|
Sale | 306 | Mar 12, 2026 | March 16, 2026, 4:31 p.m. |
NUVL
|
Sale | 24,189 | Mar 12, 2026 | March 16, 2026, 4:31 p.m. |
NUVL
|
Sale | 5,505 | Mar 12, 2026 | March 16, 2026, 4:31 p.m. |
NUVL
|
Sale | 1,703 | Mar 13, 2026 | March 16, 2026, 4:31 p.m. |
NUVL
|
Sale | 189 | Jan 06, 2026 | Jan. 7, 2026, 6:27 p.m. |
NUVL
|
Sale | 186 | Jan 05, 2026 | Jan. 7, 2026, 6:27 p.m. |
NUVL
|
Sale | 1,106 | Jan 06, 2026 | Jan. 7, 2026, 6:27 p.m. |
NUVL
|
Sale | 1,369 | Jan 06, 2026 | Jan. 7, 2026, 6:27 p.m. |
NUVL
|
Sale | 513 | Jan 05, 2026 | Jan. 7, 2026, 6:27 p.m. |
NUVL
|
Sale | 660 | Jan 05, 2026 | Jan. 7, 2026, 6:27 p.m. |
NUVL
|
Sale | 1,137 | Jan 05, 2026 | Jan. 7, 2026, 6:27 p.m. |
NUVL
|
Sale | 14,205 | Oct 15, 2025 | Oct. 17, 2025, 4:31 p.m. |
NUVL
|
Sale | 1,167 | Oct 14, 2025 | Oct. 15, 2025, 4:30 p.m. |
NUVL
|
Sale | 7,637 | Oct 13, 2025 | Oct. 15, 2025, 4:30 p.m. |
NUVL
|
Sale | 866 | Oct 14, 2025 | Oct. 15, 2025, 4:30 p.m. |
NUVL
|
Sale | 400 | Oct 14, 2025 | Oct. 15, 2025, 4:30 p.m. |
NUVL
|
Sale | 3,725 | Sep 10, 2025 | Sept. 12, 2025, 4:30 p.m. |
NUVL
|
Sale | 5,500 | Aug 07, 2025 | Aug. 8, 2025, 4:30 p.m. |
NUVL
|
Sale | 240 | Jul 10, 2025 | July 11, 2025, 4:30 p.m. |
NUVL
|
Sale | 5,260 | Jul 10, 2025 | July 11, 2025, 4:30 p.m. |
NUVL
|
Sale | 200 | Jul 09, 2025 | July 11, 2025, 4:30 p.m. |
NUVL
|
Sale | 1,945 | Jul 09, 2025 | July 11, 2025, 4:30 p.m. |
NUVL
|
Sale | 8,630 | Jun 25, 2025 | June 27, 2025, 5:05 p.m. |
NUVL
|
Sale | 2,170 | Jun 27, 2025 | June 27, 2025, 5:05 p.m. |
NUVL
|
Sale | 200 | Jun 06, 2025 | June 10, 2025, 4:38 p.m. |
NUVL
|
Sale | 712 | Jan 06, 2025 | Jan. 8, 2025, 6:05 p.m. |
NUVL
|
Sale | 428 | Jan 06, 2025 | Jan. 8, 2025, 6:05 p.m. |
NUVL
|
Sale | 1,343 | Jan 06, 2025 | Jan. 8, 2025, 6:05 p.m. |
NUVL
|
Sale | 100 | Sep 16, 2024 | Sept. 18, 2024, 4:53 p.m. |
NUVL
|
Sale | 1,966 | Sep 16, 2024 | Sept. 18, 2024, 4:53 p.m. |
NUVL
|
Sale | 3,754 | Sep 16, 2024 | Sept. 18, 2024, 4:53 p.m. |
NUVL
|
Sale | 1,548 | Sep 16, 2024 | Sept. 18, 2024, 4:53 p.m. |
NUVL
|
Sale | 4,105 | Sep 16, 2024 | Sept. 18, 2024, 4:53 p.m. |
NUVL
|
Sale | 3,197 | Sep 16, 2024 | Sept. 18, 2024, 4:53 p.m. |
NUVL
|
Sale | 706 | Sep 16, 2024 | Sept. 18, 2024, 4:53 p.m. |
NUVL
|
Sale | 4,094 | Sep 16, 2024 | Sept. 18, 2024, 4:53 p.m. |
NUVL
|
Sale | 5,513 | Sep 16, 2024 | Sept. 18, 2024, 4:53 p.m. |
NUVL
|
Sale | 7,812 | Sep 16, 2024 | Sept. 18, 2024, 4:53 p.m. |
NUVL
|
Sale | 10,500 | Aug 23, 2024 | Aug. 27, 2024, 4:49 p.m. |
$NUVL Executives and Stock Owners with Insider Trades
-
Darlene Noci, Chief Development Officer
-
Deborah Ann Miller, Chief Legal Officer
-
Alexandra Balcom, Chief Financial Officer
-
James Richard Porter, President and CEO
-
Henry E. Pelish, Chief Scientific Officer
-
Christopher Durant Turner, Chief Medical Officer
-
Darlene Noci, See Remarks
*This is only based off of information found in SEC filings, and may not reflect actual net worth. There may also be inaccuracies due to privately holdings filing errors, parsing errors, accidental double-counting of shares, incorrect classification of indirectly owned shares, sales prior to dataset start date, or any other number of issues.